Last Updated: June 2026

A behavioral health practice valuation determines what a mental health or substance-use practice is worth, and in 2026 most sell at EBITDA multiples of 5x to 12x. Platform acquisitions land at the high end and small single-location practices at the low end. Private equity has spent over $5 billion acquiring behavioral health assets since 2020, and deal volume has not slowed despite higher interest rates. If you own a behavioral health group considering a sale, the market is receptive, but the gap between what operators expect and what buyers will pay is wide for practices that have not prepared.

What separates a 5x deal from a 10x deal is almost never size. It is the payer mix, the clinician retention structure, the records quality, and whether EBITDA is real. Buyers in this space, whether regional PE-backed platforms or national acquirers, have done enough deals to spot financial engineering quickly. Sofer Advisors helps owners and their advisors work through exactly these questions and turn the analysis into a defensible business valuation they can act on.

The following takeaways summarize the key valuation and transaction factors covered in this guide.

Key Takeaways

  1. Behavioral Health EBITDA Multiples – Behavioral health EBITDA multiples range from 5x to 12x depending on size, payer mix, and EBITDA quality
  2. Private Equity Demand Remains – Private equity demand remains elevated in 2026 due to fragmented markets and recurring-revenue characteristics
  3. Commercial Payer Revenue Commands – Commercial payer revenue commands a meaningful premium over Medicaid-heavy books
  4. Clinician Retention Noncompete Structures – Clinician retention and non-compete structures are primary due diligence focus areas for buyers
  5. Practices Generating 1M+ EBITDA – Practices generating $1M+ EBITDA with diversified payer mix attract the most competitive processes
  6. Certified Valuation Sale Process – A certified valuation before any sale process protects sellers from lowball offers

Each of these factors is examined in depth in the sections that follow.

What EBITDA Multiples Apply to Behavioral Health Practices in 2026?

Behavioral health EBITDA multiples in 2026 range from 5x to 12x. The range depends on practice size, payer mix, geography, specialty mix, and whether the deal is a platform acquisition or an add-on to an existing portfolio.

Practice Type EBITDA Range Typical Multiple
Small single-site practice (<$500K EBITDA) $300K–$500K 4x–6x EBITDA
Mid-size group (3–10 locations, $500K–$2M EBITDA) $500K–$2M 6x–8x EBITDA
Regional platform ($2M–$5M EBITDA) $2M–$5M 7x–10x EBITDA
Large multi-state platform (>$5M EBITDA) $5M+ 9x–12x EBITDA
Specialty programs (ABA, eating disorder, SUD with residential) Varies 8x–13x EBITDA

These figures reflect enterprise value at close. Earnouts, common in behavioral health deals, can add 1x to 3x more tied to post-close EBITDA or revenue milestones.

The specialty premium is real. Applied behavior analysis (ABA) practices serving pediatric autism patients have traded at premium multiples. The payer setting is favorable and there is an established acquisition playbook. Eating disorder programs with residential and partial care attract strategic buyers. Those buyers will pay for licensed bed capacity and clinical programming depth.

For general outpatient mental health, the largest segment, multiples are more compressed at the lower end. The barrier to entry is low, staff turnover is high, and it is hard to stand out. Practices that have built proprietary clinical methods or assembled a mix of psychiatry and therapy services sit at the upper end of the general outpatient range.

The key multiple driver is EBITDA margin after paying market-rate clinical pay. Many practices show strong top-line revenue but thin EBITDA. Often the owner-operator has been drawing below-market salaries. Buyers underwrite on an adjusted pay basis. Practices where true EBITDA disappears after that adjustment are valued more cautiously.

A market multiple is a starting point, not a conclusion of value. A defensible fair market value still rests on the factors the IRS sets out for valuing closely held businesses under Revenue Ruling 59-60.

Why Is Private Equity Still Buying Behavioral Health in 2026?

Infographic summarising key blog_209_hero steps and value factors at Sofer Advisors

The structural reasons private equity entered behavioral health remain intact in 2026. The market is large, highly fragmented, and demand for services exceeds supply. The CDC estimates about 1 in 5 American adults experiences a mental illness in a given year. Access capacity has not kept pace. That supply-demand gap supports revenue visibility even in softer economic settings.

PE-backed platforms use a build-and-buy strategy. They acquire a regional group as a platform. Then they add smaller practices as geographic tuck-ins. The economics work because a platform acquired at 8x EBITDA can add practices at 4x–5x. This creates value through multiple arbitrage at exit. This dynamic has driven aggressive acquisition activity. It has kept multiples elevated even as deal financing costs increased.

What has changed in 2026 versus 2021–2023 is underwriting discipline. Buyers are no longer paying headline multiples on projected EBITDA. Quality of earnings reviews are more thorough. Buyers want to see at least two full years of audited or reviewed financials. They also want clean payer contracts and documented clinician agreements. Practices that struggled to close deals in 2024–2025 typically had Medicaid exposure above 60%. Others had high clinician turnover. Some had founders who were the primary revenue generators without a succession plan.

The most active acquirers include regional PE-backed platforms. These groups have already completed 5–15 deals and are building toward an exit. National providers with hospital or payer partnerships are also active. Strategic buyers from adjacent healthcare sectors expanding into mental health round out the buyer pool. All three types have active pipelines heading into the second half of 2026.

How Does Payer Mix Affect Behavioral Health Valuation?

Payer mix is one of the two or three most important valuation factors for behavioral health practices. Commercial insurance rates are typically 2x to 4x Medicaid rates for the same service. Two practices with identical patient volumes can have very different revenue and margin profiles.

A practice with 60% or more Medicaid revenue will be valued at the lower end of the applicable multiple range. This isn’t because the patients are less valuable. It’s because Medicaid rate risk, managed care carve-out exposure, and state budget reliance create earnings swings that buyers discount. Practices in states with active Medicaid managed care carve-outs face more contract risk. That risk is higher if they are not in-network with the dominant MCO.

Commercial payer focus, where a practice gets 50%+ of revenue from commercial insurers, is viewed favorably. But it creates its own risk if a single payer represents more than 25–30% of collections. Payer spread within the commercial segment is the ideal profile.

Medicare is less common in behavioral health than in other medical specialties. But psychiatric practices serving older adults with Medicare can achieve stable, reliable revenue. The 2024 CMS improvements to behavioral health billing codes expanded revenue for psychiatric services. This is a positive for practices with psychiatrists on staff.

The most sophisticated operators have managed their payer mix in the three to five years before a sale. They contract with commercial carriers and credential new clinicians with all payers. They let Medicaid capacity be absorbed by other providers. This deliberate pre-sale strategy can meaningfully shift the applicable valuation multiple.

What Role Does Telehealth Play in Behavioral Health Valuation?

Telehealth became a structural part of behavioral health delivery during the pandemic. It has remained so. In 2026, most behavioral health practices generate 30%–60% of visits via telehealth. Buyers view telehealth capacity as neutral to positive, but only if it is structured correctly.

A telehealth component adds value when it extends geographic reach without added overhead. It also improves clinician use by eliminating commute time. It increases access for patients who would not otherwise present for care. Practices that operate a hybrid in-person and telehealth model with documented outcomes have expanded their service area and revenue base.

Telehealth becomes a due diligence concern under a few conditions. First, if the practice is operating across state lines without proper licensure. Second, if reimbursement depends on temporary waivers that may sunset. Third, if telehealth revenue is heavily concentrated on new patients without shown retention. The interstate telehealth compact has expanded, but payer-by-payer reimbursement parity is still inconsistent. Buyers will stress-test telehealth revenue against current rules.

Practices that built telehealth as a complement to an established physical footprint are valued more favorably. Pure-telehealth behavioral health practices face more buyer scrutiny on patient relationships and revenue durability. Switching costs are lower on both sides of the relationship.

David Hern CPA ABV ASA, founder of Sofer Advisors, brings a Heart of a Teacher to every engagement – translating complex valuation methodology into clear, actionable guidance that clients can act on before and after the report is delivered. With 15+ years of valuation experience, 11+ expert witness cases across multiple jurisdictions, and 180+ five-star Google reviews, David built Sofer Advisors into an Inc. 5000-recognized firm. The Sofer Difference is a four-phase process of Discovery, Diligence, Analysis, and Delivery that ensures every conclusion is defensible, documented, and tied to the specific facts of the business.

While national firms like Stout and Kroll serve large enterprise clients, Sofer Advisors specializes in middle-market businesses that require personalized attention, direct access to credentialed professionals, and a next business day response policy.

What Staffing and Licensure Risks Do Buyers Underwrite?

Staffing is the primary operational risk in behavioral health. A practice’s clinical workforce, licensed professional counselors, licensed clinical social workers, psychologists, and psychiatrists, is both the revenue source and the key retention risk. If three clinicians represent 60% of revenue, the business faces concentration risk. Buyers will either price that in or walk away.

The key metrics buyers examine on staffing include: revenue per clinician on a full-time basis, clinician turnover rate over the prior 24 months, and the share of revenue from W-2 employees versus 1099 contractors. Buyers also check whether clinicians have non-solicitation and non-compete agreements. Practices built mainly on 1099 contractors face higher scrutiny on misclassification risk and retention durability.

Licensure concentration is a large deal risk. This occurs when the founding physician holds the primary DEA registration. It also occurs when that person is the named clinical director required for JCAHO or CARF accreditation. Buyers want to see that clinical operations are distributable. They do not want those operations concentrated in one person who may leave post-close.

For practices with residential or intensive outpatient components, state licensure is a standalone due diligence workstream. Any compliance gaps, survey deficiencies, complaint history, Medicaid audit findings, will be found. They will either require remediation before close or result in a price reduction.

The practices that command premium multiples have invested in clinical structure. That includes documented supervision, clear career ladders for clinicians, and competitive pay tied to productivity metrics. Signed employment agreements with proper post-employment limits are also key.

How Should Behavioral Health Owners Present Financials for a Sale?

Getting financials in order before a sale is the single highest-return pre-deal activity for most behavioral health owners. The goal is to present EBITDA that is clean, defensible, and requires minimal buyer adjustment.

The most common EBITDA adjustments buyers encounter in behavioral health include: owner pay above or below market for the clinical role, personal expenses run through the practice, and one-time items. Examples of those items are buildout costs, litigation settlements, and COVID relief funds. Revenue timing differences caused by payer billing backlogs also require records to support the add-back.

Working capital adjustment is a second area that catches sellers off guard. Behavioral health practices often carry large accounts receivable balances due to the complexity of insurance billing. Buyers will want to understand the quality of the AR, aging buckets, denial rates, days in AR. They will set a working capital peg that determines how much cash the seller walks away with at close. Practices with clean billing and AR under 45 days are in a stronger position.

Presenting three to five years of financial history is essential. Break it out by payer, service line, and location. This gives buyers the data they need. Sellers who present disorganized financials force buyers to build in more uncertainty. This always results in a lower multiple.

Revenue per clinician benchmarks vary by specialty and geography. A well-run outpatient mental health practice should generate $120,000–$200,000 in gross collections per FTE clinician each year. Margins after clinician pay should be 25%–40%. Practices outside these ranges require explanation.

The questions below address the most common issues business owners raise before engaging a qualified appraiser for a behavioral health practice valuation engagement.

Frequently Asked Questions

What EBITDA multiple should I expect for my behavioral health practice?

Most behavioral health practices trade at 5x–8x EBITDA for sub-$2M EBITDA situations. Larger platforms and specialty programs reach 9x–12x. Your specific multiple depends on payer mix, EBITDA quality, clinician structure, and how competitive your sale process is.

Does payer mix really change the valuation that much?

Yes, materially. A commercial-dominant practice can trade at 1x–3x more EBITDA than an otherwise identical Medicaid-dominant practice. The margin profile and earnings stability are very different.

Can I sell my behavioral health practice if I am the primary clinician?

You can, but it will require structuring to address clinical continuity. Buyers will typically require you to stay on for 12–36 months post-close in a clinical or supervisory role. Practices where the owner-clinician has already built a team around them are more transferable and command better pricing.

How long does a behavioral health practice sale take?

From initial process launch to close typically runs 6–12 months for a well-prepared practice.

What is a platform deal versus an add-on in behavioral health?

A platform deal is when a PE firm acquires a practice to serve as the foundation for a regional rollup. An add-on is a smaller practice acquired to be integrated into an existing platform. Platform deals typically pay higher multiples because the buyer is acquiring both the business and the management structure to build from.

Should I sell to a PE-backed group or a strategic acquirer?

Both have trade-offs. PE-backed acquirers often pay higher initial multiples and offer equity rollover, meaning you keep a stake in the combined entity. Strategic acquirers may offer better cultural fit and faster integration. The right choice depends on your personal financial goals and post-close involvement preferences.

What due diligence should I expect from a buyer?

Expect financial due diligence (quality of earnings review), clinical and operational due diligence (staffing, licensure, credentialing, accreditation), legal review (contracts, employment agreements, corporate structure), and compliance review (billing practices, HIPAA). Plan for 60–90 days of intensive diligence after a LOI is signed.

What happens to my clinicians after a sale?

That depends on the buyer. PE-backed platforms typically retain all clinical staff and often improve pay structures to reduce turnover.

How do I know if my EBITDA is clean enough for a sale process?

A quality of earnings review will identify adjustments buyers will make to your stated EBITDA. Running a sell-side QofE before launch lets you get ahead of issues and present clean figures from the start.

Is telehealth revenue counted the same as in-person revenue in a valuation?

In most cases, yes, if the revenue is fully reimbursable under current payer contracts and there are no outstanding regulatory concerns. Buyers will look at telehealth revenue stability and whether reimbursement parity exists across your payer mix.

Related Case Studies

Executive Summary

  • Behavioral health EBITDA multiples range from 5x to 12x in 2026, with size, payer mix, and EBITDA quality as the primary drivers
  • Private equity demand remains structurally strong due to market fragmentation and durable service demand
  • Commercial payer concentration commands a premium over Medicaid-heavy practices
  • Clinician retention, licensure structure, and non-compete agreements are primary buyer due diligence focus areas

What Should You Do Next?

If you own a behavioral health practice and are considering a sale, recapitalization, or exit in the next one to five years, a certified business valuation is the right first step. David Hern CPA ABV ASA, founder of Sofer Advisors, holds dual ASA and ABV credentials recognized by the IRS, SEC, and FINRA, with 15+ years of valuation experience and 180+ five-star Google reviews. Schedule a consultation to discuss your business valuation needs.

People Also Read

About the Author

This guide was prepared by David Hern CPA ABV ASA, founder of Sofer Advisors – a business valuation firm headquartered in Atlanta, GA serving clients across the United States. David holds dual accreditations as an Accredited Senior Appraiser (ASA) and is Accredited in Business Valuation (ABV), credentials recognized by the IRS, SEC, and FINRA. He also holds the Certified Exit Planning Advisor (CEPA) designation. With 15+ years of valuation experience, David has served as an expert witness in 11+ cases across multiple jurisdictions and built Sofer Advisors into an Inc. 5000-recognized firm with 180+ five-star Google reviews. The firm’s full W2 employee team maintains subscriptions to all major valuation databases and operates under a next business day response policy.

For professional business valuation services, visit soferadvisors.com/about-us/ or schedule a consultation at soferadvisors.com/contact-us/.

This content is for informational purposes only and does not constitute professional valuation advice. Business valuation conclusions depend on specific facts and circumstances. Contact Sofer Advisors for guidance regarding your specific situation.